Literature DB >> 3329106

Use of tenoxicam in patients with acute gouty arthritis.

E F Valdés1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3329106

Source DB:  PubMed          Journal:  Eur J Rheumatol Inflamm        ISSN： 0140-1610


× No keyword cloud information.
  4 in total

Review 1.  Gout treatment: what is evidence-based and how do we determine and promote optimized clinical care?

Authors:  Ted R Mikuls; Kenneth G Saag
Journal:  Curr Rheumatol Rep       Date:  2005-06       Impact factor: 4.592

Review 2.  Outcome measures in acute gout: a systematic literature review.

Authors:  Nicola Dalbeth; Cathy S Zhong; Rebecca Grainger; Dinesh Khanna; Puja P Khanna; Jasvinder A Singh; Fiona M McQueen; William J Taylor
Journal:  J Rheumatol       Date:  2013-12-15       Impact factor: 4.666

Review 3.  Non-steroidal anti-inflammatory drugs for acute gout.

Authors:  Caroline Mpg van Durme; Mihir D Wechalekar; Robert Bm Landewé; Jordi Pardo Pardo; Sheila Cyril; Désirée van der Heijde; Rachelle Buchbinder
Journal:  Cochrane Database Syst Rev       Date:  2021-12-09

4.  Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative.

Authors:  Francisca Sivera; Mariano Andrés; Loreto Carmona; Alison S R Kydd; John Moi; Rakhi Seth; Melonie Sriranganathan; Caroline van Durme; Irene van Echteld; Ophir Vinik; Mihir D Wechalekar; Daniel Aletaha; Claire Bombardier; Rachelle Buchbinder; Christopher J Edwards; Robert B Landewé; Johannes W Bijlsma; Jaime C Branco; Rubén Burgos-Vargas; Anca I Catrina; Dirk Elewaut; Antonio J L Ferrari; Patrick Kiely; Burkhard F Leeb; Carlomaurizio Montecucco; Ulf Müller-Ladner; Mikkel Ostergaard; Jane Zochling; Louise Falzon; Désirée M van der Heijde
Journal:  Ann Rheum Dis       Date:  2013-07-18       Impact factor: 19.103
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.